Prospects of treating CLL and their complications
How to explain the 'watch-and-wait' period to a CLL patient?
Myeloma 2016: Panel discussion on the environment biology of myeloma
Dirk Hose et al.
Venetoclax for multiple myeloma - mechanism of action and next steps
Preliminary results of a phase Ib study combining ABT-199 and obinutuzumab in CLL